Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
21.81
+5.55 (34.13%)
At close: May 6, 2026, 4:00 PM EDT
21.20
-0.61 (-2.81%)
After-hours: May 6, 2026, 7:59 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $582.64 million as of May 6, 2026. Its market cap has increased by 1,137.03% in one year.
Market Cap
582.64M
Enterprise Value
484.73M
1-Year Change
1,137.03%
Ranking
Category
Stock Price
$21.81
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $582.64M, an increase of 1,588.81%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 370.50M | 12.51% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 607.24M |
| Altimmune | 606.87M |
| Entrada Therapeutics | 581.66M |
| Contineum Therapeutics | 579.83M |
| ProKidney | 579.77M |
| Ginkgo Bioworks Holdings | 576.54M |
| Candel Therapeutics | 572.06M |
| Adlai Nortye | 570.80M |